The family of slain hostage Shiri Bibas said on Saturday that remains returned to Israel the day before were identified to be ...
UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...
Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...
Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...
Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...
Hims & Hers Health, Inc. stock surged 1,000% with strategic growth, but high valuation & short interest suggest taking ...
Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback